NEUMANN MARK (EVP, Chief Commercial Officer) exercised options at INTRA-CELLULAR THERAPIES, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/4/2025ACC: 0000950170-25-032585
Officer· EVP, Chief Commercial Officer
Since Oct 2018
-3.71K
Net shares
Net seller
$475.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
8.74K acquired · 12.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.74K
Price / share
—
Trade value
—
% of position
24.3%
3/1/2025
35.99K→44.73K
Common Stock
Direct
Shares
−3.71K
Price / share
$128.20
Trade value
$475.49K
% of position
8.3%
3/1/2025
44.73K→41.02K
Total
Net shares
+5.03K
Net value
-$475.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | M · Option Exercise | +8.74K | — | — | 24.3% | 35.99K | 44.73K |
| Common Stock Direct | 3/1/2025 | F · Tax Withholding | −3.71K | $128.20 | $475.49K | 8.3% | 44.73K | 41.02K |
| Total | +5.03K | -$475.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
8.74K shares
Shares
−8.74K
Strike price
Held after
17.48K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8.74K shares | 3/1/2025 | M · Option Exercise | −8.74K | — | 17.48K |